HDFC Mutual Fund launches HDFC Pharma and Healthcare Fund...
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance tha...
Read MoreTo provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance tha...
Read MoreThe investment objective of the scheme is to provide returns before expenses that correspond to the total return of the underlying index subject to tracking errors. Howev...
Read MoreThe investment objective of the scheme is to seek to generate returns by investing in arbitrage opportunities in the cash and derivatives segments of the equity markets a...
Read MoreThe investment objective of the scheme is to seek to generate long term capital appreciation by investing in multi asset classes including equity and equity related secur...
Read MoreThe investment objective of the fund is to generate long term capital appreciation/income by investing in equity and debt instruments. However, there is no assurance or g...
Read MoreThe primary objective of the scheme is to provide long-term capital appreciation/income by investing across market capitalisations and managing a diversified portfolio of...
Read MoreThe investment objective of the scheme is to generate long term capital appreciation by investing in Equity & Equity related Securities, Debt & Money Market Instruments, ...
Read MoreTo provide long-term capital appreciation by investing predominantly in equity and equity related securities of Technology & technology related companies. There is no ass...
Read MoreThe primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related instruments of technology-centric compa...
Read MoreThe investment objective of the scheme is to generate returns that are commensurate with the performance of the S&P BSE SENSEX Index, subject to tracking errors. There is...
Read More